Oseltamivir Phosphate Capsule
Product Images NDC 64380-797

7 FDA label images from Strides Pharma Science Limited · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Oseltamivir Phosphate (NDC 64380-797). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Strides Pharma Science Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Dd6b1302 1dff 43d7 9c1a F3d657f24339 01)

Chemical Structure (Dd6b1302 1dff 43d7 9c1a F3d657f24339 01)
Chemical structure of Oseltamivir Phosphate showing its molecular framework and functional groups as depicted in the image.*
FDA Label Image

Principal Display Panel (Carton-30)

Principal Display Panel (Carton-30)
Packaging label for Oseltamivir Phosphate Capsules, USP 30 mg by Strides Pharma Science Limited. The label includes the NDC 64380-797-01, indicates the package contains 10 unit-dose capsules, and states storage conditions at controlled room temperature. The label features the manufacturer and distributor information and a barcode.*
FDA Label Image

Principal Display Panel (Carton-45mg)

Principal Display Panel (Carton-45mg)
Packaging label for Oseltamivir Phosphate Capsules, USP 45 mg by Strides Pharma Science Limited. The label indicates a 10-count package of 45 mg capsules, with Strides Pharma Inc. as the distributor. Storage instructions and barcode are also present. The label includes NDC 64380-798-01 and a revision date of 09/2025.*
FDA Label Image

Principal Display Panel (Carton-75mg)

Principal Display Panel (Carton-75mg)
Packaging label for Oseltamivir Phosphate Capsules, USP, 75 mg by Strides Pharma Science Limited. The box contains 10 capsules in unit-dose packaging. Label includes storage instructions, manufacturer and distributor addresses, barcode, NDC 64380-799-01, and revision date 09/2025.*
FDA Label Image

Principal Display Panel (30 mg foil)

Principal Display Panel (30 mg foil)
Strip labels for Oseltamivir Phosphate capsules from Strides Pharma Science Limited. The labels display the product name, dosage strength of 75 mg per capsule, and include barcode and identification codes. The layout is designed for cutting into individual dose labels, each marked with 'PEEL TO OPEN' instructions.*
FDA Label Image

Principal Display Panel (45 mg foil)

Principal Display Panel (45 mg foil)
Sheet of multiple Oseltamivir Phosphate oral capsule labels displaying various strengths including 30 mg, 45 mg, and 75 mg. Each label shows the product name, strength, dosage form as capsules, and the labeler Strides Pharma Science Limited. The labels contain barcodes and instructions to peel to open.*
FDA Label Image

Principal Display Panel (75 mg foil)

Principal Display Panel (75 mg foil)
Packaging label sheet for Oseltamivir Phosphate capsules, 75 mg strength, from Strides Pharma Science Limited. The label includes multiple identical barcode panels, each stating the product name, dosage strength, and 'PEEL TO OPEN' instructions for individual capsules, intended for human prescription drug use.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.